Nicole Steinmetz
Affiliations: | Biomedical Engineering | Case Western Reserve University, Cleveland Heights, OH, United States |
Google:
"Nicole Steinmetz"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| González-Gamboa I, Caparco AA, McCaskill J, et al. (2024) Inter-coat protein loading of active ingredients into Tobacco mild green mosaic virus through partial dissociation and reassembly of the virion. Scientific Reports. 14: 7168 |
| Barkovich KJ, Zhao Z, Steinmetz NF. (2023) iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Delivery. Small Science. 3 |
| Barkovich KJ, Wu Z, Zhao Z, et al. (2023) Physalis Mottle Virus-Like Nanocarriers with Expanded Internal Loading Capacity. Bioconjugate Chemistry |
| Jung E, Chung YH, Steinmetz NF. (2023) TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy. Bioconjugate Chemistry |
| Ma Y, Wu Z, Steinmetz NF. (2023) In Vitro and Ex Planta Gold-Bonded and Gold-Mineralized Tobacco Mosaic Virus. Langmuir : the Acs Journal of Surfaces and Colloids. 39: 11238-11244 |
| Shah S, Famta P, Tiwari V, et al. (2022) Instigation of the epoch of nanovaccines in cancer immunotherapy. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1870 |
| Nkanga CI, Steinmetz NF. (2022) Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth. Acs Biomaterials Science & Engineering. 8: 2518-2525 |
| Nkanga CI, Ortega-Rivera OA, Shin MD, et al. (2022) Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate. Biomacromolecules |
| Beiss V, Mao C, Fiering SN, et al. (2022) Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy. Molecular Pharmaceutics |
| Koellhoffer EC, Mao C, Beiss V, et al. (2022) Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model. Molecular Pharmaceutics |